Bellerophon Therapeutics Inc (NASDAQ:BLPH)

4.16
Delayed Data
As of Jul 23
 -0.23 / -5.24%
Today’s Change
3.79
Today|||52-Week Range
13.87
-37.63%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Bellerophon Therapeutics Inc have a median target of 28.00, with a high estimate of 30.00 and a low estimate of 26.00. The median estimate represents a +573.08% increase from the last price of 4.16.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Bellerophon Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.62
Sales
$0.00
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -14.28%
 
 
 
 
 
 
Growthannually 23.97%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.